Reversibilit�t von pathologischen Serum-Labilit�tsproben, Elektrophoresediagramm und Leberfunktionstests bei chronischen Lebererkrankungen (chronische Hepatitis, Lebercirrhosen) unter Sulfonylharnstoffgaben (D 860)

Knick, B; Emrich, K

doi:10.1007/bf01485723

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1960

1971

Publication Types

Select...

Book4

Article2

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 15 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Such an idea was based on the assumption that augmenting glycogen in the liver must have a beneficial effect on the damaged liver. Knick and Emrich (1957) used tolbutamide, 3 g. daily for three to six weeks, in six cases of chronic hepatitis and six cases of liver cirrhosis without diabetes and reported increased appetite, decrease in serum bilirubin, marked restoration to normal of the serum proteins, and improvement in the bromsulphalein test. Improvement in bromsulphalein excretion was also reported in a diabetic patient by Pote, Anderson, and Cochran (1959).…”

mentioning

confidence: 99%